Page last updated: 2024-10-31

nocodazole and Carcinoma, Squamous Cell

nocodazole has been researched along with Carcinoma, Squamous Cell in 7 studies

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"Esophageal cancer is a common malignancy with a high mortality rate."1.39Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells. ( Cai, Y; Hu, M; Jiang, F; Liu, C; Liu, Q; Luo, J; Luo, M; Shi, Q; Song, P; Tang, M; Weng, Y; Yang, D; Zhan, X; Zhang, F; Zhang, Y; Zhou, L; Zuo, G, 2013)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, M1
Liu, Q1
Song, P1
Zhan, X1
Luo, M1
Liu, C1
Yang, D1
Cai, Y1
Zhang, F1
Jiang, F1
Zhang, Y1
Tang, M1
Zuo, G1
Zhou, L1
Luo, J1
Shi, Q1
Weng, Y1
Reimer, TA1
Anagnostopoulos, I1
Erdmann, B1
Lehmann, I1
Stein, H1
Daniel, P1
Dörken, B1
Rehm, A1
Zhang, Z1
Mitra, RS1
Henson, BS1
Datta, NS1
McCauley, LK1
Kumar, P1
Lee, JS1
Carey, TE1
D'Silva, NJ1
Medvedeva, ND1
Chupreta, SV1
D'iakonova, MIu1
Tvorogov, DB1
Blagoveshchenskaia, AD1
Tsupkina, NV1
Nikol'skiĭ, NN1
Gröne, A1
Weckmann, MT1
Capen, CC1
Rosol, TJ1
Akiyama, T1
Shimizu, M1
Okabe, M1
Tamaoki, T1
Akinaga, S1
De Brabander, M1
Nuydens, R1
Geerts, H1
Hopkins, CR1

Other Studies

7 other studies available for nocodazole and Carcinoma, Squamous Cell

ArticleYear
Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells.
    Oncology reports, 2013, Volume: 29, Issue:1

    Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcinoma, Squamous Cell; Cell Cycle; Cell Prolifer

2013
Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker.
    BMC cancer, 2005, May-17, Volume: 5

    Topics: Adenocarcinoma; Antibodies, Monoclonal; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate

2005
Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma.
    The American journal of pathology, 2006, Volume: 168, Issue:2

    Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Proliferation; Cells, Cultured; Cycli

2006
[The effect of nocodazole on the redistribution of phosphoinositide-specific phospholipase C gamma 1 during mitogenic signal transduction in A-431 cells].
    Tsitologiia, 1997, Volume: 39, Issue:9

    Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Epidermal Growth Factor; ErbB Receptors; Humans; Is

1997
Regulation of parathyroid hormone-related protein expression in a canine squamous carcinoma cell line by colchicine.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 1998, Volume: 50, Issue:4-6

    Topics: Animals; Blotting, Northern; Carcinoma, Squamous Cell; Colchicine; Dogs; Epidermal Growth Factor; Ge

1998
Differential effects of UCN-01, staurosporine and CGP 41 251 on cell cycle progression and CDC2/cyclin B1 regulation in A431 cells synchronized at M phase by nocodazole.
    Anti-cancer drugs, 1999, Volume: 10, Issue:1

    Topics: Alkaloids; Antineoplastic Agents; Carcinoma, Squamous Cell; CDC2 Protein Kinase; cdc25 Phosphatases;

1999
Dynamic behavior of the transferrin receptor followed in living epidermoid carcinoma (A431) cells with nanovid microscopy.
    Cell motility and the cytoskeleton, 1988, Volume: 9, Issue:1

    Topics: Alkaloids; Azides; Benzimidazoles; Carcinoma, Squamous Cell; Cell Line; Cell Membrane; Humans; Micro

1988